TheraRadar
Data updated: May 26, 2026

QUININE SULFATE

Infectious Disease Approved 2012-09-28

QUININE SULFATE is indicated for the treatment of Malaria.

Source: FDA Label • NOVAST LABS
5
Indications
--
Phase 3 Trials
13
Years on Market

Details

Status
Prescription
First Approved
2012-09-28
Routes
ORAL
Dosage Forms
CAPSULE

QUININE SULFATE Approval History

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
16 FDA actions from 2012 to 2025
Aug 2025 SUPPL
Mfg · Manufacturing (CMC)
Aug 2024 SUPPL
Label · Labeling
Dec 2019 SUPPL
Label · Labeling

What QUININE SULFATE Treats

1 indications

QUININE SULFATE is approved for 1 conditions since its original approval in 2012. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Malaria
Source: FDA Label

QUININE SULFATE Boxed Warning

HEMATOLOGIC REACTIONS [see FULL PRESCRIBING INFORMATION for complete boxed warning] Quinine sulfate capsules use for the treatment or prevention of nocturnal leg cramps may result in serious and life-threatening hematologic reactions, including thrombocytopenia and hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP). Chronic renal impairment associated with the development of TTP has been reported. The risk associated with quinine sulfate capsules use in the absence of eviden...

QUININE SULFATE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 5 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to QUININE SULFATE

3 of 7

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ARAKODA
TAFENOQUINE SUCCINATE
1 shared
60 DEGREES PHARMS
Shared indications:
Malaria
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
ATOVAQUONE
1 shared
GLENMARK PHARMS LTD
Shared indications:
Malaria
COARTEM
ARTEMETHER
1 shared
Novartis
Shared indications:
Malaria
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT02630472 QSIND results posted 821731 Ph 1, Ph 2 terminated Topical Irrigation Therapy for CRS
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

QUININE SULFATE FDA Label Details

Indications & Usage

QUININE SULFATE is indicated for the treatment of Malaria.

⚠️ BOXED WARNING

WARNING: HEMATOLOGIC REACTIONS [see FULL PRESCRIBING INFORMATION for complete boxed warning] Quinine sulfate capsules use for the treatment or prevention of nocturnal leg cramps may result in serious and life-threatening hematologic reactions, including thrombocytopenia and hemolytic uremic syndrome...

Looking for the branded version?

QUALAQUIN

Full clinical data, patents, trials, and competitive landscape for quinine sulfate.

See QUALAQUIN

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.